Pennsylvania SB269 amends the Newborn Child Testing Act to include screening for Duchenne muscular dystrophy.
Pennsylvania SB269 amends the Newborn Child Testing Act to expand the Newborn Child Screening and Follow-up Program. The bill requires the Department of Health to include screening for Duchenne muscular dystrophy in newborn screening tests. The program aims to assist health care providers in determining necessary treatments to prevent intellectual disability, physical disability, or death. The changes will take effect 60 days after the act's passage.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.